Señales en vivo de ECOR | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 16:00):

electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies...

Stats
Volumen de hoy	6 384.00
Volumen promedio	9 673.00
Capitalización de mercado	37.97M
EPS	$0 ( 2024-05-01 )
Próxima fecha de ganancias	( $-0.500 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.850
ATR14	$0.114 (1.80%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-16	Goldberger Daniel S	Buy	75 000	Common Stock
2024-01-12	Posner Brian M	Buy	16 000	Common Stock
2024-01-01	Theofilos Charles Steve	Buy	25 210	Common Stock
2023-12-08	Theofilos Charles Steve	Sell	0	Common Stock
2023-12-08	Theofilos Charles Steve	Buy	0	Common Stock

INSIDER POWER
100.00
Last 93 transactions
Buy: 5 593 347 \| Sell: 60 242

electroCore, Inc. Correlación

10 Correlaciones Más Positivas
RING	0.919
IGLD	0.895
FATP	0.89
BWBBP	0.885
LBTYA	0.878
LBTYK	0.878
GLBZ	0.869
CSBR	0.868
RGLD	0.864
FSFG	0.854

10 Correlaciones Más Negativas
CINC	-0.854
BPOPN	-0.829
OBT	-0.823
GVP	-0.821
CELC	-0.82
LUNA	-0.813
HCM	-0.813
WSC	-0.811
GETVV	-0.808
INSE	-0.807

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

electroCore, Inc. Finanzas

Annual	2023
Ingresos:	$16.03M
Beneficio Bruto:	$13.23M (82.51 %)
EPS:	$-3.42

FY	2023
Ingresos:	$16.03M
Beneficio Bruto:	$13.23M (82.51 %)
EPS:	$-3.42

FY	2022
Ingresos:	$8.59M
Beneficio Bruto:	$6.98M (81.19 %)
EPS:	$-4.69

FY	2021
Ingresos:	$5.45M
Beneficio Bruto:	$4.07M (74.59 %)
EPS:	$-0.290

Financial Reports:

No articles found.

electroCore, Inc.

electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Actualizaciones en tiempo real para electroCore, Inc. [ECOR]

Upcoming Earnings Alert